InspireMD (NSPR) Liabilities and Shareholders Equity (2010 - 2025)
InspireMD (NSPR) posted quarterly Liabilities and Shareholders Equity of $69.4 million for Q4 2025, up 48.28% year-over-year from $46.8 million in Q4 2024, and down 11.56% quarter-over-quarter from $78.5 million in Q3 2025.
InspireMD (NSPR) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
InspireMD's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $69.4 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 48.28% year-over-year to $69.4 million; the TTM figure through Dec 2025 stood at $219.9 million (up 12.78% YoY), while the FY2025 annual figure was $69.4 million, up 48.28% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $69.4 million, down from $78.5 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $78.5 million in Q3 2025, with the low at $19.9 million in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $44.5 million (2021), against an average of $44.2 million.
- The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity soared 558.56% in 2021, then sank 43.36% in 2023.
- InspireMD's Liabilities and Shareholders Equity stood at $39.7 million in 2021, then slumped by 37.92% to $24.7 million in 2022, then jumped by 93.25% to $47.6 million in 2023, then retreated by 1.75% to $46.8 million in 2024, then soared by 48.28% to $69.4 million in 2025.
- Business Quant data shows NSPR's Liabilities and Shareholders Equity at $69.4 million in Q4 2025, $78.5 million in Q3 2025, and $33.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn | 69.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.40 Mn |
| Sep 30, 2025 | 78.47 Mn |
| Jun 30, 2025 | 33.34 Mn |
| Mar 31, 2025 | 38.67 Mn |
| Dec 31, 2024 | 46.81 Mn |
| Sep 30, 2024 | 50.48 Mn |
| Jun 30, 2024 | 55.66 Mn |
| Mar 31, 2024 | 42.03 Mn |
| Dec 31, 2023 | 47.64 Mn |
| Sep 30, 2023 | 50.02 Mn |
| Jun 30, 2023 | 53.64 Mn |
| Mar 31, 2023 | 19.92 Mn |
| Dec 31, 2022 | 24.65 Mn |
| Sep 30, 2022 | 28.06 Mn |
| Jun 30, 2022 | 32.77 Mn |
| Mar 31, 2022 | 35.17 Mn |
| Dec 31, 2021 | 39.71 Mn |
| Sep 30, 2021 | 42.61 Mn |
| Jun 30, 2021 | 46.38 Mn |
| Mar 31, 2021 | 48.64 Mn |